Platelet Concentration Systems Market projected to reach USD 1,313.16 Million by 2030, growing at a CAGR of 19.3% during the forecast period of 2023-2030 - says MarketDigits in its latest study

The Global Platelet Concentration Systems Market was valued USD 381.8 Million in 2023 and projected to reach USD 1,313.16 Million by 2030, growing at a CAGR of 19.3% during the forecast period of 2023-2030

Richmond, March 04, 2024 (GLOBE NEWSWIRE) -- According to a research report "Platelet Concentration Systems Market, by Technology (Single Spin Technology, Double Spin Technology, and Apheresis Technology), Application (Orthopedics & Sport Medicine, Pain Rehabilitation & Pain Management, Cosmetic & Aesthetic Medicine, Neurology, Veterinarian, Cardiology, and Others), End-User (Blood Banks and Transfusion Centers, Hospital and Clinics, Sports Injury Centers, Ambulatory Surgical Centers, and Others) and Region-Global Forecast to 2030.

Global Platelet Concentration Systems Market Report Scope:

Report Details
Market size value in 2023 USD 381.8 Million
Market size value in 2030 USD 1,313.16 Million
CAGR (2023-2030) 19.3%
Forecast Period 2023–2030
Historic Data 2019
Forecast Units Value (USD Million/USD Billion)
Segments Covered Technology, Application, End User and Region
Geographies Covered North America, Europe, Asia Pacific, and RoW
  • Haemonetics Corporation
  • Arthrex, Inc
Sample of Companies Covered
  • BioIVT
  • Exactech, Inc
  • Fresenius SE & Co. KGaA

Download the Sample -

TOC Covers in Depth & Breath on Platelet Concentration Systems Market
170 - Market Data Tables
65 - List of Figures
225 – Pages

The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.

Market Overview

Platelet concentration systems play an important role in the field of regenerative medicine and blood-related therapies. These systems are designed to harvest and concentrate platelets from a patient's own blood, facilitating the creation of platelet-rich plasma (PRP). PRP is rich in growth factors and cytokines, which are essential for tissue repair, regeneration, and healing. Platelet Concentration Systems find applications in various medical disciplines, including orthopedics, sports medicine, dermatology, and dentistry.

The market for platelet concentration systems seen significant growth, driven by the rising demand for advanced and minimally invasive treatments. Factors such as an aging population, increasing prevalence of chronic diseases, and a growing emphasis on personalized medicine have contributed to the expanding adoption of platelet-rich plasma therapies. The systems vary in design and functionality, offering a range of options to healthcare providers. Key players Terumo Cardiovascular Systems Corporation, Zimmer Biomet, and Arthrex, Inc in the market are continually investing in research and development to enhance the efficiency and versatility of these systems. Moreover, the increasing awareness among both healthcare professionals and patients about the benefits of platelet concentration systems is likely to fuel market growth further. As the medical community continues to explore and expand the applications of platelet-rich plasma, the platelet concentration systems market is expected to evolve, providing innovative solutions for a diverse array of medical conditions and driving advancements in the broader field of regenerative medicine.

Major vendors in the global Platelet Concentration Systems market are

  • Arthrex, Inc.
  • BioIVT
  • Exactech, Inc.
  • Fresenius SE & Co. KGaA
  • Haemonetics Corporation
  • Harvest Technologies
  • Isto Biologics
  • Johnson & Johnson Services, Inc.
  • Macopharma
  • Stago
  • Terumo Cardiovascular Systems Corporation
  • Zimmer Biomet

Request for Discount @

The Rising Prevalence of Chronic Conditions

The primary drivers for the global platelet concentration systems market is the rising prevalence of chronic conditions. Chronic diseases, including osteoarthritis, tendinopathy, and cardiovascular conditions, have become increasingly common, demanding innovative therapeutic approaches for improved patient outcomes. Platelet concentration systems offer a promising solution by harnessing the regenerative potential of platelet-rich plasma (PRP). In conditions like osteoarthritis, where traditional treatment options may provide limited relief, PRP therapies derived from platelet concentration systems have gained attention for their ability to stimulate tissue repair and alleviate symptoms. The rise in chronic diseases can be attributed to factors such as aging populations, sedentary lifestyles, and changing dietary habits, contributing to an upsurge in musculoskeletal and cardiovascular issues. As these conditions often require long-term management and may not be fully addressed by conventional treatments, the regenerative capabilities of platelet concentration systems become increasingly valuable.

Market Dynamics


  • Growing preference for minimally invasive treatment
  • The rising prevalence of chronic conditions
  • Increasing shift toward personalized and patient-centric healthcare
  • Increasing awareness among healthcare professionals and patients about the benefits of platelet-rich plasma


  • Growing interest in regenerative therapies
  • Ongoing innovations in Platelet Concentration Systems
  • Strategic collaborations between healthcare institutions and technology

Ongoing innovations in platelet concentration systems

The ongoing innovations in platelet concentration systems represent a significant opportunity that holds the potential to change the landscape of regenerative medicine. As technology continues to advance, there is a continuous pursuit to enhance the efficiency, precision, and versatility of platelet concentration systems. Innovations in device design, automation, and extraction methodologies are driving improvements in the reproducibility and quality of platelet-rich plasma (PRP) produced by these systems. Innovative features, such as closed-system processing and real-time monitoring, contribute to the standardization of PRP production, addressing concerns related to variability and ensuring consistent therapeutic outcomes. The integration of advanced technologies, such as microfluidics and advanced centrifugation techniques, allows for more precise control over the concentration of platelets and growth factors in the final product. Additionally, the exploration of novel biomaterials and surface coatings within platelet concentration systems aims to optimize platelet activation and maximize the regenerative properties of PRP. These ongoing innovations enhance the performance of platelet concentration systems and also facilitate their seamless integration into clinical practice.

North America dominates the market for platelet concentration systems.

In North America, platelet concentration systems have seen strong growth, driven by the region's advanced healthcare infrastructure, increasing prevalence of chronic diseases, and a proactive approach toward adopting advanced medical technologies. The demand is particularly prominent in the U.S., where a well-established healthcare system and a high awareness level among healthcare professionals contribute to the widespread adoption of platelet concentration systems., further propel market expansion.

In the Asia-Pacific region, platelet concentration systems are experiencing a rise in demand, reflecting the growing emphasis on healthcare modernization and a rising awareness of regenerative medicine. Countries like China and Japan are at the forefront of this adoption, driven by substantial investments in healthcare infrastructure and increasing research initiatives. The Asia-Pacific market is also characterized by a significant patient population seeking innovative treatment options, fostering the adoption of platelet concentration systems in diverse medical disciplines.

Another noteworthy region is the Middle East and Africa, experiencing a rising demand for Platelet concentration systems driven by factors like an aging population and increased healthcare expenditure. However, challenges include regulatory hurdles, limited awareness, and infrastructure issues. Opportunities lie in ongoing research and collaborations.

Inquire Before Buying:

The single spin technology segment is anticipated to hold the largest market share during the forecast period

In the global platelet concentration systems market, the technology segment comprises various categories such as single spin technology, double spin technology, and apheresis technology. Single spin technology represents a significant advancement in platelet concentration systems, streamlining the process of platelet-rich plasma (PRP) separation in a single centrifugation step. This innovative technology offers a more efficient and simplified method compared to traditional multi-step processes. The key feature of single spin technology is its ability to concentrate platelets from a small volume of blood or bone marrow in a single centrifugation cycle, reducing processing time and optimizing platelet yield. This approach enhances the overall productivity of platelet concentration procedures and also minimizes the risk of contamination and ensures consistent and reliable results. The efficiency of single spin technology lies in its ability to isolate platelets with high purity and concentration, making it a valuable tool in various medical applications, including orthopedics, sports medicine, and dermatology. This technology's simplicity and effectiveness make it a prominent segment within the platelet concentration systems market, driving interest and adoption among healthcare professionals looking for reliable and efficient platelet separation methods.

Segmentations Analysis of Platelet Concentration Systems Market: -

  • By Technology
    • Single Spin Technology
    • Double Spin Technology
    • Apheresis Technology
  • By Application
    • Orthopedics & Sport Medicine
    • Pain Rehabilitation & Pain Management
    • Cosmetic & Aesthetic Medicine 
    • Neurology
    • Veterinarian
    • Cardiology
    • Others
  • By End-User
    • Blood Banks and Transfusion Centers
    • Hospital and Clinics
    • Sports Injury Centers
    • Ambulatory Surgical Centers
    • Others
  • By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East & Africa

Avail 25% Discount on Direct Purchase - Click the below link to proceed:

Browse Similar Reports:

Platelet Function Test Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints by MarketDigits

Platelet Rich Plasma Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem  Competitive Index & Regional Footprints by MarketDigits

Europe Platelet Rich Plasma (PRP) Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints by MarketDigits

About MarketDigits:

MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.

We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.

Contact Us:
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Follow Us on: | Twitter | LinkedIn |